Status:
UNKNOWN
Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals
Lead Sponsor:
Progentec Diagnostics, Inc.
Conditions:
Lupus Erythematosus, Systemic
Lupus Erythematosus
Eligibility:
All Genders
18+ years
Brief Summary
OASIS: A mobile study to measure and predict lupus (SLE) disease activity using digital signals The OASIS study is exploring how patient reported data and digital biomarkers, like activity level and h...
Eligibility Criteria
Inclusion
- Female or male age 18 or older
- Participant is currently not enrolled in another study
- Able to understand the requirements of the study, provide written informed consent, including consent for the use and disclosure of research-related health information, and comply with the study data collection procedures
Exclusion
- NOT able to understand the requirements of the study, provide written informed consent, including consent for the use and disclosure of research-related health information, and comply with the study data collection procedures
- Known to be pregnant
Key Trial Info
Start Date :
April 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04449653
Start Date
April 28 2020
End Date
June 1 2021
Last Update
June 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ryan Newhardt
Oklahoma City, Oklahoma, United States, 73104